{"id":105148,"date":"2023-07-12T14:57:02","date_gmt":"2023-07-12T09:27:02","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=105148"},"modified":"2023-07-12T15:47:58","modified_gmt":"2023-07-12T10:17:58","slug":"multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/","title":{"rendered":"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-676556965\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2682282919\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalization of Rs 4,600 crores, the stocks of Marksans Pharma Limited are currently trading at Rs 102 gaining 10 percent compared to the previous closing levels of Rs 93.50 apiece. The stock witnessed an intra-day high price of Rs 103 which is also marked as the company\u2019s new 52-week high level.&nbsp;<\/p><p>Keeping a horizon of one year, the scrip has been successful in delivering multibagger returns of 110 percent meaning a 1 Lakh investment into the stock would have converted to Rs 2.10 Lakhs within the mentioned period.&nbsp;<\/p><p>Such movements in the stock prices were observed after the company, through a regulatory filing with the BSE, announced that it has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for \u2018Acetaminophen\u2019 and \u2018Ibuprofen\u2019 tablets, an over-the-counter (OTC) bioequivalent of Advil Dual Action Tablets.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1879791343\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>By combining the above-mentioned ingredients, multiple pain-related symptoms would be able to get comparatively faster relief. On one hand, Acetaminophen blocks pain signals to the brain, and, on the other hand, Ibuprofen works through the body targeting pain at the source.&nbsp;<\/p><p>Digging into the financials, the company has consistently increased its operating revenues with the most recent movement being from Rs 1,490 crores during FY21-22 to Rs 1,852 crores in FY22-23. In congruence with the above, the after-tax profits increased from Rs 186 crores to Rs 265 crores.&nbsp;<\/p><p>According to the shareholding data available for the March 2023 quarter, the Promoters hold a 43.85 percent stake, and Foreign Institutional Investors (FIIs) hold a 15.11 percent stake in the company.&nbsp;<\/p><p>Marksans Pharma Limited is a pharmaceutical company engaged in the business of manufacturing as well as marketing pharmaceutical formulations related to anti-diabetic, gastrointestinal, cardiovascular, and antiallergic medications.&nbsp;<\/p><p><strong>Written by Amit Madnani<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-1117783175\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.&nbsp; With a market capitalization of Rs 4,600 crores, the stocks of Marksans Pharma Limited are currently trading at Rs 102 gaining 10 percent compared to the previous closing [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31],"tags":[],"class_list":["post-105148","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0\" \/>\n<meta property=\"og:description\" content=\"Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-12T09:27:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-12T10:17:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/\",\"url\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/\",\"name\":\"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-07-12T09:27:02+00:00\",\"dateModified\":\"2023-07-12T10:17:58+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0 - Trade Brains Features","description":"Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/","og_locale":"en_US","og_type":"article","og_title":"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0","og_description":"Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-07-12T09:27:02+00:00","article_modified_time":"2023-07-12T10:17:58+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/","url":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/","name":"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-07-12T09:27:02+00:00","dateModified":"2023-07-12T10:17:58+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of this small-cap Pharma stock gained 10 percent to hit its 52-week high level today. In the last one-month, the stock has gained around 15 percent.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/multibagger-pharma-stock-jumps-10-after-usfda-gives-approval-for-pain-relief-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Multibagger Pharma stock jumps 10% after USFDA gives approval for pain relief drug\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=105148"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105148\/revisions"}],"predecessor-version":[{"id":105149,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105148\/revisions\/105149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=105148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=105148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=105148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}